The effect of type and concentration of vehicles on the dissolution rate of a poorly soluble drug (indomethacin) from liquisolid compacts

Journal of Pharmacy and Pharmaceutical Sciences

Volumn 8, Issue 1, 2005, Pages 18-25

  Nokhodchi, Ali ^a   Javadzadeh, Yousef ^b   Siahi Shadbad, Mohammad Reza ^b   Barzegar Jalali, Mohammad ^b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

CELLULOSE; DRUG CARRIER; DRUG VEHICLE; INDOMETACIN; PROPYLENE GLYCOL; SILICON DIOXIDE;

ACIDITY; ALKALINITY; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CRYSTAL; DRUG CAPSULE; DRUG COATING; DRUG SOLUBILITY; LIQUID; PH; SOLID; SURFACE PROPERTY; TABLET;

CHEMISTRY, PHARMACEUTICAL; COMPRESSIVE STRENGTH; DRUG CARRIERS; INDOMETHACIN; SOLUBILITY; SOLVENTS; TABLETS, ENTERIC-COATED; VEHICLES;

EID: 27444438012     PISSN: 14821826     EISSN: 14821826     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Lobenberg R, Amidon GL Modern bioavailability, bioequivalence and biopharmaceutics classification system; new scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm., 50: 3-12,2000.
2. Kapsi SG, Ayres JW. Processing factors in development of solid solution formulation of itraconazole for enhancement of drug dissolution and bioavailability. Int. J. Pharm.; 229: 193-203, 2001.
3. Aguiar AJ, Zelmer AJ, Kinkel AW. Deagglomeration behavior of relatively insoluble benzoic acid and its sodium salt. J. Pharm. Sci.; 56:1243-1252, 1967.
4. Finholt P, Solvang S. Dissolution kinetics of drugs in human gastric juice the role of surface tension. J. Pharm. Sci.; 57:1322-1326, 1968.
5. Lin SL, Menig J, Lachman L., Interdependence of physiological surfactant and drug particle size on the dissolution behavior of water insoluble drugs. J. Pharm. Sci.; 57: 2143-2146, 1968.
6. Spireas S, Sadu S. Enhancement of Prednisolone dissolution properties using liquisolid compacts. Int.. J. Pharma.; 166: 177-188, 1998.
7. Spireas S, Sadu S, Grover R. In vitro release evaluation of hydrocortisone liquisolid tablets, J. Pharm. Sci.; 87: 867-872, 1998.
8. Spireas S, Wang T, Grover R. Effect of powder substrate on the dissolution properties of methchrothiazide liquisolid compacts. Drug Dev. Ind. Pharm.; 25: 163-168, 1999.
9. Alsaidan SM, Alsughayer AA, Eshra AG. Improved dissolution rate of indomethacin by adsorbents. Drug Dev. Ind. Pharm.; 24 (4): 389-394, 1998.
10. Krasowska H. Solubilization of indomethacin and cinmetacin by non-ionic surfactants of the polyoxyethylene type. Il Farmaco; 31 (9): 463-472, 1976.
11. Krasowska, H. Effect of micellar solubilization on the gastrointestinal absorption of indomethacin in the rat. Int. J. Pharm.; 7: 137-143, 1980.
12. Habib MJ, Akogyeram C, Ahmadi B. Improved dissolution of indomethacin in coprecipitates with phospholipids. Part 1. Drug Dev. Ind. Pharm.; 19 (4): 499, 1993.
13. Khaled K.A., Asiri Y.A., EI-Sayed Y.M. In vivo evaluation of hydrochlorothiazide liquisolid tablets in beagle dogs. Int. J. Pharm.; 222: 1-6, 2001.
14. Noyes AA, Whitney WR. The rate of solution of solid substances in their own solutions. J. Am. Chem. Soc.; 19: 930-934, 1897.
15. El-Moneim Darvish 1, El-Kamal A. H. Dissolution enhancement of glibenclamide using liquisolid tablets technology. Acta Pharm. 51:173-181, 2001.